Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ansofaxine hydrochloride (LY03005) 是一种血清素-去甲肾上腺素-多巴胺再摄取抑制剂,IC50值分别为723、491 和 763 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 528 | 现货 | ||
2 mg | ¥ 778 | 现货 | ||
5 mg | ¥ 1,330 | 现货 | ||
10 mg | ¥ 2,320 | 现货 | ||
25 mg | ¥ 3,960 | 现货 | ||
50 mg | ¥ 5,660 | 现货 | ||
100 mg | ¥ 7,900 | 现货 | ||
500 mg | ¥ 15,800 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,430 | 现货 |
产品描述 | Ansofaxine hydrochloride (LY03005) is a serotonin-norepinephrine-dopamine reuptake inhibitor (IC50s: 723, 763 and 491 nM, respectively). |
靶点活性 | Norepinephrine:763 nM, Dopamine:491 nM, 5-HT:723 nM |
体内活性 | Acute administration was performed by providing rodents with oral solutions (0.06 mmol/kg p.o.), oral suspensions (0.06 mmol/kg p.o.) and intravenous solutions (0.04 mmol/kg i.v.) of LPM570065 and desvenlafaxine. Oral suspensions (0.06 mmol/kg/day) of the two drugs were also administered for a 14-day chronic period. LPM570065 rapidly penetrated the rat striatum, converted into desvenlafaxine and exhibited larger total exposure compared with the administration of desvenlafaxine. Acute and chronic administration of oral suspension of LPM570065 increased the 5-HT, DA and NE levels more than the relative administration of desvenlafaxine [1]. The maximum tolerated dose (MTD) was 500?mg/kg and the lethal dose was 1000?mg/kg in SD rats after a single administration of LPM570065. In 13-week repeated-dose oral toxicity, the no-observed-adverse-effect level (NOAEL) of LPM570065 was greater than 300?mg/kg for rats [2]. |
动物实验 | The dosages of LPM570065 and desvenlafaxine used with different administration routes referred to previous studies and was determined by preliminary experiments. Oral solutions of LPM570065 and desvenlafaxine for intragastric administration (0.06 mmol/kg p.o.) were prepared by dissolving the compounds in 10% glucose. Oral suspensions of LPM570065 and desvenlafaxine for intragastric administration (0.06 mmol/kg p.o.) were prepared by suspending the compounds in 0.5% carboxymethylcellulose sodium. Intravenous solutions of LPM570065 and desvenlafaxine for intravenous administration (0.04 mmol/kg i.v.) were prepared by dissolving the compounds in 10% glucose. WAY-100635 was dissolved in 0.9% saline and was administered subcutaneously (0.3 mg/kg s.c.). Raclopride was dissolved in 0.9% saline and was administered subcutaneously (0.5 mg/kg s.c.). Different vehicles were used for administration using different administration routes [1]. |
别名 | Ansofaxine盐酸盐, LPM570065, LY03005 |
分子量 | 417.97 |
分子式 | C24H32ClNO3 |
CAS No. | 916918-84-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (71.77 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.3925 mL | 11.9626 mL | 23.9252 mL | 59.8129 mL |
5 mM | 0.4785 mL | 2.3925 mL | 4.785 mL | 11.9626 mL | |
10 mM | 0.2393 mL | 1.1963 mL | 2.3925 mL | 5.9813 mL | |
20 mM | 0.1196 mL | 0.5981 mL | 1.1963 mL | 2.9906 mL | |
50 mM | 0.0479 mL | 0.2393 mL | 0.4785 mL | 1.1963 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Ansofaxine hydrochloride 916918-84-8 GPCR/G Protein Neuroscience Dopamine Receptor 5-HT Receptor Norepinephrine Ansofaxine盐酸盐 5-hydroxytryptamine Receptor inhibit Ansofaxine Hydrochloride Serotonin Receptor LY 03005 LPM570065 Ansofaxine LPM 570065 Inhibitor LPM-570065 LY03005 LY-03005 inhibitor